Gabapentin Capsule
Product Images NDC 71335-2773

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 71335-2773). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig-1 (Gabapentin Fig1)

Fig-1 (Gabapentin Fig1)
This text provides information about a medical test result, specifically mentioning values related to serum creatinine levels. It also includes numbers such as 140, 40, 08, 65, 2, and 72. This data may be part of a medical report or analysis.*
FDA Label Image

Figure 1 (Gabapentin Fig2)

Figure 1 (Gabapentin Fig2)
This text seems to be a table showing the Mean Pain Score for different periods and treatments. It includes data related to the placebo and Gabapentin at a dose of 3600 mg/day over certain weeks. The layout suggests a clinical study evaluating pain relief effectiveness.*
FDA Label Image

Figure 2 (Gabapentin Fig3)

Figure 2 (Gabapentin Fig3)
This text provides information about a study on pain management, specifically related to Gabapentin treatment. It mentions different dose periods and conditions, as well as the baseline data for the study participants.*
FDA Label Image

Figure 3 (Gabapentin Fig4)

Figure 3 (Gabapentin Fig4)
This is a chart showing the proportion of responders (patients with a 50% or more reduction in pain score) in controlled PHN studies. The studies are labeled as Study 1 and Study 2. The data in the chart indicates the percentages of responders in each study group, including those receiving placebo (PBO), GBP 3600, GBP 1800, and GBP 2400. The statistical significance is also provided at the bottom with the p-values.*
FDA Label Image

Fig-5 (Gabapentin Fig5)

FDA Label Image

Chemical Structure (Gabapentin Str)

FDA Label Image

Label (Lbl713352773)

Label (Lbl713352773)
The provided text appears to be a product label for Gabapentin capsules. Each capsule contains 400 mg of Gabapentin, USP. The capsules are to be stored at 20° to 25°C (68° to 77°F) with excursions permitted to 15° to 30°C (59° to 86°F). It is important to keep this medication out of reach of children and to dispense in tight, child-resistant containers. The label also includes a National Drug Code (NDC) for identification purposes. Additionally, it mentions scanning a QR code for full prescribing information and advises pharmacists to dispense the medication guide to each patient. The capsules are manufactured by Aurobindo Pharma Limited and repackaged by Bryant Ranch Prepack, Inc.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.